FDA Approves Telix Pharma’s NDA For Pixclara, Amino Acid Positron Emission Tomography Drug For Imaging Gliomas
Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer).Approval addresses a significant unmet need, helping physicians to differentiate recurrent or progressive glioma from treatment-related
Telix got government approval for a new brain cancer imaging tool. This means doctors can now better see and treat brain tumors.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.